|
|
 |
|
Viewing report
|
|
|
|
Osteoporosis Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., March 2008, Pages: 278
This report analyzes the worldwide markets for Osteoporosis Therapeutics in Millions of US$. The specific product segments analyzed are Bisphosphonates, ERT Drugs, SERMs, and Calcitonins. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2015.
The report profiles 52 companies including many key and niche players worldwide such as Eli Lilly and Company, F.Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Novo Nordisk, Organon, Procter & Gamble Pharmaceuticals, Inc., Sanofi-Aventis SA, Servier SA, Solvay Pharmaceuticals, Inc., Unigene Laboratories, Inc., and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
U.S. Emerging Osteoporosis Therapeutics Markets
Osteoporosis: Strategic Audit of Marketplace Activity, Issues and Implications
Therapeutic and Pharmaceutical Opportunities for Osteoporosis and Atherosclerosis
Orthopedic Orthotics - Global Strategic Business Report
Trauma Devices - Global Strategic Business Report
Anti-Aging Products - Global Strategic Business Report
Intranasal Drug Delivery - Global Strategic Business Report
Bone Grafts - Global Strategic Business Report
Drug Delivery for Self-Administration Report - Technologies, Combination
Biotech Revolution, The (Technical Insights)
Premium Company Profile: GTx, Inc.
Premium Company Profile Nastech Pharmaceutical
|
|
|
|
